Effect of time to relapse on overall survival (OS) in mantle cell lymphoma (MCL) patients (pts) following frontline high-dose therapy and autologous hematopoietic cell transplantation (autoHCT) Meeting Abstract


Authors: Riedell, P. A.; Hamadani, M.; Ahn, K. W.; Litovich, C.; Kharfan-Dabaja, M.; Herrera, A. F.; Sauter, C. S.; Smith, S. M.
Abstract Title: Effect of time to relapse on overall survival (OS) in mantle cell lymphoma (MCL) patients (pts) following frontline high-dose therapy and autologous hematopoietic cell transplantation (autoHCT)
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120604118
DOI: 10.1200/JCO.2021.39.15_suppl.7521
PROVIDER: wos
Notes: Meeting Abstract: 7521 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Steven Sauter
    334 Sauter